Marco A. Zarbin0000-0002-7811-7132
Marco A. Zarbin was graduated from Dartmouth College, NH, USA (and received the M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, Baltimore, MD, USA. He completed ophthalmology residency at the Wilmer Ophthalmological Institute (Johns Hopkins) and was corecipient of the Francis S. Schwentker Award. He completed fellowships in vitreoretinal surgery and in medical retinal disease at Wilmer and was an Assistant Chief of service at Wilmer. Zarbin is Chair of the Institute of Ophthalmology and Visual Science, New Jersey Medical School, NJ, USA, and the Chief of Ophthalmology at the University Hospital in Newark, NJ, USA. In addition, he is a Professor of ophthalmology and neuroscience. Zarbin's research is focused on developing cell-based therapy for retinal disease. He is Editor-in-Chief of Translational Vision Science and Technology. Zarbin is on the Scientific Advisory Board of the Foundation Fighting Blindness. He is an Ex-officio Member of the National Advisory Eye Council of the National Institutes of Health. Moreover, he is a Member of the American Ophthalmological Society, the Retina Society, the Macula Society, and the Vitreous Society. He was a Past President of the Association of University Professors of Ophthalmology. He has served as a Member of the Preferred Practice Pattern Committee (Retina) of the American Academy of Ophthalmology, a Chair of the Retinal Cell Biology Program Planning Committee of the Association of Research in Vision and Ophthalmology (ARVO), and a Chair of the Professional Development and Education Committee of ARVO. His clinical practice is limited to medical and surgical diseases of the retina and vitreous with special expertise in age-related macular degeneration, trauma management, complex retinal detachment (including retinopathy of prematurity), and macular surgery.
Biography Updated on 5 March 2014